Elevated endoplasmic reticulum pH is associated with high growth and bisAb aggregation in CHO cells
Chinese hamster ovary (CHO) bioprocesses, the dominant platform for therapeutic protein production, are increasingly used to produce complex multispecific proteins. Product quantity and quality are affected by intracellular conditions, but these are challenging to measure and often overlooked during process optimization studies. pH is known to impact quality attributes like protein aggregation across upstream and downstream processes, yet the effects of intracellular pH on cell culture performance are largely unknown. Recently, advances in protein biosensors have enabled investigations of intracellular environments with high spatiotemporal resolution. In this study, we integrated a fluorescent pH-sensitive biosensor into a bispecifc (bisAb)-producing cell line to investigate changes in endoplasmic reticulum pH (pH<sub>ER</sub>). We then investigated how changes in lactate metabolism impacted pH<sub>ER</sub>, cellular redox, and product quality in fed-batch and perfusion bioreactors. Our data show pH<sub>ER</sub> rapidly increased during exponential growth to a maximum of pH 7.7, followed by a sharp drop in the stationary phase in all perfusion and fed-batch conditions. pH<sub>ER</sub> decline in the stationary phase was driven by an apparent loss of cellular pH regulation that occurred despite differences in redox profiles. Finally, we found protein aggregate levels correlated most closely with pH<sub>ER</sub> which provides new insights into product aggregate formation in CHO processes. An improved understanding of the intracellular changes impacting bioprocesses can ultimately help guide media optimizations, improve bioprocess control strategies, or provide new targets for cell engineering.
Authors
- Michael J. Betenbaugh (ORCID: https://orcid.org/0000-0002-6336-4659)
- Michael W. Handlogten (ORCID: https://orcid.org/0000-0002-6508-3228)
- Kevin S. McFarland
- Kaitlin Hegadorn
Institutions
- Johns Hopkins University (US)
- AstraZeneca (United States) (US)
Publication Details
- Journal
- Biotechnology and Bioengineering
- Published
- 2024-10-22
- DOI
- https://doi.org/10.1002/bit.28866
- Citations
- 3
- Primary Topic
- Viral Infectious Diseases and Gene Expression in Insects
- Type
- article
- Field-Weighted Citation Impact
- 0.70